Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation.
McIntyre RS, Rosenblat JD, Nemeroff CB, Sanacora G, Murrough JW, Berk M, Brietzke E, Dodd S, Gorwood P, Ho R, Iosifescu DV, Lopez Jaramillo C, Kasper S, Kratiuk K, Lee JG, Lee Y, Lui LMW, Mansur RB, Papakostas GI, Subramaniapillai M, Thase M, Vieta E, Young AH, Zarate CA Jr, Stahl S. McIntyre RS, et al. Among authors: papakostas gi. Am J Psychiatry. 2021 May 1;178(5):383-399. doi: 10.1176/appi.ajp.2020.20081251. Epub 2021 Mar 17. Am J Psychiatry. 2021. PMID: 33726522 Free PMC article. Review.
Nortriptyline for treatment-resistant depression.
Nierenberg AA, Papakostas GI, Petersen T, Kelly KE, Iacoviello BM, Worthington JJ, Tedlow J, Alpert JE, Fava M. Nierenberg AA, et al. Among authors: papakostas gi. J Clin Psychiatry. 2003 Jan;64(1):35-9. doi: 10.4088/jcp.v64n0108. J Clin Psychiatry. 2003. PMID: 12590621 Clinical Trial.
Serum cholesterol in treatment-resistant depression.
Papakostas GI, Petersen T, Sonawalla SB, Merens W, Iosifescu DV, Alpert JE, Fava M, Nierenberg AA. Papakostas GI, et al. Neuropsychobiology. 2003;47(3):146-51. doi: 10.1159/000070584. Neuropsychobiology. 2003. PMID: 12759558 Clinical Trial.
Axis III disorders in treatment-resistant major depressive disorder.
Papakostas GI, Petersen T, Iosifescu DV, Roffi PA, Alpert JE, Rosenbaum JF, Fava M, Nierenberg AA. Papakostas GI, et al. Psychiatry Res. 2003 May 30;118(2):183-8. doi: 10.1016/s0165-1781(03)00067-2. Psychiatry Res. 2003. PMID: 12798983 Clinical Trial.
Obesity among outpatients with major depressive disorder.
Papakostas GI, Petersen T, Iosifescu DV, Burns AM, Nierenberg AA, Alpert JE, Rosenbaum JF, Fava M. Papakostas GI, et al. Int J Neuropsychopharmacol. 2005 Mar;8(1):59-63. doi: 10.1017/S1461145704004602. Epub 2004 Sep 13. Int J Neuropsychopharmacol. 2005. PMID: 15361263 Free article. Clinical Trial.
Empirical testing of two models for staging antidepressant treatment resistance.
Petersen T, Papakostas GI, Posternak MA, Kant A, Guyker WM, Iosifescu DV, Yeung AS, Nierenberg AA, Fava M. Petersen T, et al. Among authors: papakostas gi. J Clin Psychopharmacol. 2005 Aug;25(4):336-41. doi: 10.1097/01.jcp.0000169036.40755.16. J Clin Psychopharmacol. 2005. PMID: 16012276
236 results